Prelude Therapeutics cut the ribbon on its new headquarters on Friday morning, signaling the next chapter in the company's growth.
WILMINGTON – Seeking to gain an edge in the race to find a new cancer drug, Incyte has signed a new research collaboration and license agreement with a San Diego […]
WILMINGTON – Biopharmaceutical giant Incyte Corp. announced Monday that it has bought into a new collaboration deal on a monoclonal antibody, paying about $152 million to Massachusetts-based clinical stage company […]
WILMINGTON – Incyte Corp. reported a “disappointing” conclusion Monday to its study of its blockbuster drug Jakafi to fight the effects of COVID-19 in hospitalized patients. The pharmaceutical company headquartered […]
WILIMINGTON – Global biopharmaceutical company Incyte announced April 2 that it was studying whether it could repurpose its blockbuster drug Jakafi to aid in the treatment of COVID-19 patients. The […]
Premier Digital Partners
© 2024 Delaware Business Times
